当前位置: 首页 > 期刊 > 《医学信息》 > 20146
编号:13698989
90Sr(锶90)—90Y(钇90)β射线腔内照射治疗前列腺增生症的临床观察(2)
http://www.100md.com 2014年2月12日 《医学信息》 20146
     [4]Stone NN, Ratnow ER, Stock RG. Prior transurethral resection does not increase morbidity following real-time ultrasound-guided prostate seed implantation[J].Tech Urol, 2000;6:123 -127.

    [5]De Nunzio C, Kramer G, Marberger M, et al. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation[J].European urology, 2011, 60(1): 106-117.

    [6]Schenk J M, Kristal A R, Arnold K B, et al. Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial[J].American journal of epidemiology,2011,173(12):1419-1428.

    [7]Alaiya A A, Al-Mohanna M, Aslam M, et al. Proteomics-based signature for human benign prostate hyperplasia and prostate adenocarcinoma[J].International journal of oncology,2011,38(4):1047-1057.

    [8]Yan M, Hardin K, Ho E. Differential response to zinc-induced apoptosis in benign prostate hyperplasia and prostate cancer cells[J]. The Journal of Nutritional Biochemistry,2010,21(8): 687-694.

    编辑/肖慧, http://www.100md.com(王建 曾广品)
上一页1 2